白人とアジア人におけるMOG抗体関連視神経炎の臨床的特徴の差異
多施設後方視的コホート研究で、成人発症MOG-IgG陽性視神経炎患者153例(白人80例、アジア人73例)を比較した。白人は再発性視神経炎と視神経外症状が有意に多かったが、視神経乳頭腫脹、画像所見、初診時視力、治療、最終視力に人種差はなかった。最終視力は両群とも良好な回復を示した。
要点
- 最終視力は白人66%、アジア人74%が>20/40と良好で人種差なし。
核心结论
- 白人MOG-ON患者はアジア人患者より再発性疾患と視神経外症状を多く呈するが、視力転帰は同様である。
研究设计与样本
- 多施設後方視的コホート研究で、成人発症(18歳以上)MOG-IgG陽性視神経炎患者153例(白人80例、アジア人73例)を対象とした。
主要发现
- 視神経乳頭腫脹、神経画像所見、初診時視力、治療、最終視力は人種間で差がなかった。
- 最終検査で視力>20/40の割合は白人51/77例(66%)、アジア人52/70例(74%)であった。
关键数值与推荐
- 最終視力>20/40の割合:白人66%対アジア人74%。
临床怎么用
- 白人MOG-ON患者では再発や視神経外症状の監視をより慎重に行う必要がある。
- 人種にかかわらず視力予後は比較的良好であるため、急性期治療は同様の方針でよい可能性がある。
局限性
- 後方視的コホート研究であり、公開コホートの症例レベルデータを含むため選択バイアスや情報バイアスの可能性がある。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To determine whether clinical features and visual outcomes of myelin oligodendrocyte glycoprotein antibody-associated optic neuritis (MOG-ON) differ between White and Asian subjects. DESIGN: Multicenter retrospective cohort. METHODS: This was a multicenter study of 153 subjects who were White or Asian with a history of adult-onset (age 18 years or older) optic neuritis (ON) and positive MOG-IgG serology by cell-based assay. Subjects were enrolled from 2 unpublished cohorts (January 2017-November 2019) and 9 published cohorts with case-level data available (2012-2018). Subjects with alternative etiologies of demyelinating disease and positive or lack of aquaporin-4-IgG serology result were excluded. The main outcome measurements were clinical features and final visual outcomes. RESULTS: Of the 153 subjects who were White (n = 80) or Asian (n = 73) included in the study, 93 (61%) were women, mean age of onset was 40.8 ± 14.9 years, and median follow-up was 35.2 months (range: 1-432 months); all of these characteristics were similar between White and Asian subjects. White subjects were more likely to have recurrent ON (57 [71%] vs 20 [27%]; P = .001) and extra-optic nerve manifestations (35 [44%] vs 8 [11%]; P = .001). Optic disc swelling, neuroimaging findings, presenting visual acuity (VA), treatment, and final VA did not differ according to subjects' race. Despite the high prevalence of severe visual loss (<20/200) during nadir, most subjects had good recovery of VA (>20/40) at final examination (51/77 [66%] White subjects vs 52/70 [74%] Asian subjects). CONCLUSION: White subjects with MOG-ON were more likely to have recurrent disease and extra-optic nerve manifestations. Visual outcomes were similar between White and Asian subjects.
引用
- Padungkiatsagul T, Chen JJ, Jindahra P, et al. Differences in Clinical Features of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis in White and Asian Race. Am J Ophthalmol. 2020. PMID: 32681910. doi:10.1016/j.ajo.2020.07.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。